Airway Stent Global Market Report 2026

An airway stent is a medical device designed to maintain open airways, ensuring proper airflow for individuals with narrowed or obstructed airways due to conditions like tumors, strictures, or other respiratory disorders. They are used to treat obstructions in the trachea, bronchi, or larynx, improving breathing and lung function.

The primary types of airway stents include tracheal stents, laryngeal stents, and bronchial stents. Tracheal stents specifically support and keep the trachea open, addressing issues such as tumors or strictures that narrow or obstruct this crucial airway. These stents come in various forms, including expandable and non-expandable options, and are made from materials such as metal, silicon, or hybrid substances. They are used in diverse settings including hospitals, clinics, home healthcare, ambulatory surgical centers, laboratories, and research facilities.

Tariffs are impacting the airway stent market by increasing the cost of raw materials, metal alloys, silicone components, and precision-manufactured expandable stents sourced across international supply chains, leading to higher production and procurement expenses for hospitals and clinics. These effects are most visible in regions dependent on imports from North America, Europe, and Asia-Pacific manufacturing hubs, particularly across bronchial and tracheal stent segments. However, tariffs have also stimulated localization of manufacturing, supplier diversification, and partnerships with regional producers, which may support long-term cost optimization and improved supply resilience.

The airway stent market research report is one of a series of new reports from The Business Research Company that provides airway stent market statistics, including airway stent industry global market size, regional shares, competitors with a airway stent market share, detailed airway stent market segments, market trends and opportunities, and any further data you may need to thrive in the airway stent industry. This airway stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The airway stent market size has grown strongly in recent years. It will grow from $10.66 billion in 2025 to $11.46 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing prevalence of tracheal and bronchial strictures, rising incidence of lung cancer and airway tumors, growth in hospital-based interventional pulmonology procedures, increasing availability of metal and silicone stent materials, expanding adoption of palliative respiratory obstruction management.

The airway stent market size is expected to see strong growth in the next few years. It will grow to $15.27 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to rising demand for minimally invasive respiratory interventions, increasing uptake of hybrid and biodegradable airway stents, growth in outpatient and ambulatory airway stenting procedures, expanding clinical awareness of airway stent therapy outcomes, increasing adoption of precision-fit and customized airway stents. Major trends in the forecast period include increasing adoption of minimally invasive airway stent placement procedures for respiratory obstruction management, rising demand for patient-specific and anatomically tailored stent designs, growing use of biocompatible and hybrid stent materials to improve durability and tolerance, increasing clinical usage of airway stents in oncology-related airway obstruction cases, expanding utilization of airway stents across hospitals, ambulatory centers, and specialized respiratory care settings.

The growing prevalence of lung diseases and respiratory disorders is anticipated to drive the expansion of the airway stent market in the coming years. Lung diseases and respiratory disorders comprise a wide range of conditions that affect the lungs and respiratory system, leading to impaired breathing and reduced lung function. The rising incidence of these conditions is attributed to factors such as increasing pollution levels, smoking behaviors, exposure to environmental toxins, and an aging population. In addition, lifestyle changes and genetic predispositions further contribute to the increasing burden of these health issues. Airway stents are used in the management of lung diseases and respiratory disorders to provide structural support to the airways, relieve obstructions, and enhance airflow in patients suffering from conditions such as tracheal stenosis or bronchial tumors. For example, in May 2024, according to the National Center for Health Statistics, a US-based health statistics agency, the prevalence of current asthma among adults aged 18 years and older reached 8.7% in 2022, while asthma episodes reported within the past 12 months increased to 3.7% during the same year. Consequently, the rising prevalence of lung diseases and respiratory disorders is contributing to the growth of the airway stent market.

Major companies operating in the airway stent market are emphasizing technological advancements, including patient-specific 3D-printed silicone airway devices, to improve device fit, minimize complications, and address complex anatomies that standard stents cannot adequately accommodate. A patient-specific 3D-printed T-tube is custom designed using a patient's CT imaging data and manufactured from medical-grade silicone to match individual airway geometry, thereby reducing issues such as mucus plugging, granulation tissue formation, and vocal cord interference commonly associated with poorly fitting conventional tubes. For instance, in July 2024, University Hospitals, a US-based health system, implanted the first-in-human patient-specific 3D-printed tracheal T-tube under FDA compassionate-use approval in collaboration with VisionAir Solutions, a US-based medical device company specializing in patient-specific silicone airway stents. The customized T-tube, developed directly from the patient's CT scan and tailored to precise airway dimensions, resulted in fewer complications, improved vocal function, and longer replacement intervals compared with previously used commercial T-tubes.

In August 2023, Theken Companies, a US-based medical device manufacturer known for innovative orthopedic and spinal solutions, acquired VisionAir Solutions from Cleveland Clinic for an undisclosed amount. This acquisition was aimed at strengthening Theken Companies' airway management portfolio, expanding its presence in the medical device market, supporting growth through a broader product offering, and improving patient outcomes in airway management. VisionAir Solutions is a US-based provider of advanced airway management technologies.

Major companies operating in the airway stent market are Medtronic Plc, Boston Scientific Corporation, Olympus Corporation, Teleflex Incorporated, Cook Medical, KARL STORZ SE & Co. KG, Merit Medical Systems, MICRO-TECH (Nanjing) Co. Ltd., Taewoong Medical Co. Ltd., Alvimedica Medical Technologies Inc, M.I. Tech Co. Ltd., Pnn Medical A/S, Endo-Flex GmbH, InSitu Technologies, QualiMed Innovative Medizinprodukte GmbH, Novatech SA, Boston Medical Products Inc., Meditek Systems Pvt. Ltd., AndraTec GmbH, Allium Medical Solutions Ltd., Medi-Globe GmbH, Bess medizintechnik GmbH

North America was the largest region in the airway stent market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the airway stent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the airway stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The airway stent market consists of sales of Y-shaped stents, biodegradable stents, and uncovered stents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Airway Stent Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses airway stent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for airway stent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The airway stent market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Anatomical Site: Tracheal Stents; Laryngeal Stents; Bronchial stents
• 2) By Product Type: Expandable Stents; Non-Expandable Stents
• 3) By Material Type: Metal; Silicone; Hybrid
• 4) By End-User: Hospitals; Clinics
• Subsegments:
• 1) By Tracheal Stents: Silicone Tracheal Stents; Metallic Tracheal Stents; Hybrid Tracheal Stents
• 2) By Laryngeal Stents: Silicone Laryngeal Stents; Self-Expanding Laryngeal Stents; Biodegradable Laryngeal Stents
• 3) By Bronchial Stents: Metallic Bronchial Stents; Silicone Bronchial Stents; Covered Bronchial Stents; Self-Expanding Bronchial Stents
• Companies Mentioned: Medtronic Plc; Boston Scientific Corporation; Olympus Corporation; Teleflex Incorporated; Cook Medical; KARL STORZ SE & Co. KG; Merit Medical Systems; MICRO-TECH (Nanjing) Co. Ltd.; Taewoong Medical Co. Ltd.; Alvimedica Medical Technologies Inc; M.I. Tech Co. Ltd.; Pnn Medical A/S; Endo-Flex GmbH; InSitu Technologies; QualiMed Innovative Medizinprodukte GmbH; Novatech SA; Boston Medical Products Inc.; Meditek Systems Pvt. Ltd.; AndraTec GmbH; Allium Medical Solutions Ltd.; Medi-Globe GmbH; Bess medizintechnik GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.